{"id":70232,"date":"2026-04-13T15:43:46","date_gmt":"2026-04-13T10:13:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=70232"},"modified":"2026-04-13T15:43:48","modified_gmt":"2026-04-13T10:13:48","slug":"why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/","title":{"rendered":"Why Is Torrent Pharmaceuticals Share Price Falling? Key Reasons &amp; Share Price Target 2026"},"content":{"rendered":"<p>Torrent Pharmaceuticals share price is down -27% from its 52-week high of Rs 3,900, trading at Rs 2,850 as of April 2026. At its 52-week low of Rs 2,600, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap?<\/p><p>The Torrent Pharmaceuticals share price falling is not random market noise. There are specific, identifiable reasons driving the decline \u2014 and this article examines each of them with real data, sector context, and the analyst consensus on what Torrent Pharmaceuticals is worth.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Why_Is_Torrent_Pharmaceuticals_Share_Price_Falling_Key_Reasons\" title=\"Why Is Torrent Pharmaceuticals Share Price Falling? Key Reasons\">Why Is Torrent Pharmaceuticals Share Price Falling? Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_1_Curatio_Acquisition_Integration_%E2%80%94_Dermatology_Focus\" title=\"Reason 1: Curatio Acquisition Integration \u2014 Dermatology Focus\">Reason 1: Curatio Acquisition Integration \u2014 Dermatology Focus<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_2_Germany_Business_%E2%80%94_Pricing_and_Competition\" title=\"Reason 2: Germany Business \u2014 Pricing and Competition\">Reason 2: Germany Business \u2014 Pricing and Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_3_Brazil_Business_%E2%80%94_Currency_Risk\" title=\"Reason 3: Brazil Business \u2014 Currency Risk\">Reason 3: Brazil Business \u2014 Currency Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_4_High_Working_Capital_in_Branded_Generics\" title=\"Reason 4: High Working Capital in Branded Generics\">Reason 4: High Working Capital in Branded Generics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_5_Valuation_vs_Growth_Justification\" title=\"Reason 5: Valuation vs Growth Justification\">Reason 5: Valuation vs Growth Justification<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Torrent_Pharmaceuticals_Financial_Snapshot\" title=\"Torrent Pharmaceuticals Financial Snapshot\">Torrent Pharmaceuticals Financial Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Can_Torrent_Pharmaceuticals_Recover_Future_Outlook\" title=\"Can Torrent Pharmaceuticals Recover? Future Outlook\">Can Torrent Pharmaceuticals Recover? Future Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Torrent_Pharmaceuticals_Share_Price_Target_2026\" title=\"Torrent Pharmaceuticals Share Price Target 2026\">Torrent Pharmaceuticals Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Short-Term_Target_3-6_Months\" title=\"Short-Term Target (3-6 Months)\">Short-Term Target (3-6 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Long-Term_Target_FY28\" title=\"Long-Term Target (FY28)\">Long-Term Target (FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q1_Why_is_Torrent_Pharmaceuticals_share_price_falling_in_2026\" title=\"Q1. Why is Torrent Pharmaceuticals share price falling in 2026?\">Q1. Why is Torrent Pharmaceuticals share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q2_What_is_Torrent_Pharmaceuticals_share_price_target_2026\" title=\"Q2. What is Torrent Pharmaceuticals share price target 2026?\">Q2. What is Torrent Pharmaceuticals share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q3_Should_I_buy_Torrent_Pharmaceuticals_at_current_levels\" title=\"Q3. Should I buy Torrent Pharmaceuticals at current levels?\">Q3. Should I buy Torrent Pharmaceuticals at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q4_What_is_Torrent_Pharmaceuticalss_market_cap_and_PE_ratio\" title=\"Q4. What is Torrent Pharmaceuticals&#8217;s market cap and P\/E ratio?\">Q4. What is Torrent Pharmaceuticals&#8217;s market cap and P\/E ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q5_What_can_trigger_recovery_in_Torrent_Pharmaceuticals_share_price\" title=\"Q5. What can trigger recovery in Torrent Pharmaceuticals share price?\">Q5. What can trigger recovery in Torrent Pharmaceuticals share price?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-torrent-pharmaceuticals-share-price-falling-key-reasons-amp-share-price-target-2026\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Is_Torrent_Pharmaceuticals_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Torrent Pharmaceuticals Share Price Falling? Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_1_Curatio_Acquisition_Integration_%E2%80%94_Dermatology_Focus\"><\/span><strong>Reason 1: Curatio Acquisition Integration \u2014 Dermatology Focus<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent Pharmaceuticals acquired Curatio Healthcare (specialty dermatology) for Rs 2,000 crore in FY24 to strengthen its dermatology franchise. The integration has been ongoing through FY25-26. While the Curatio brands (Tedibar, Clensta) are strong in dermatology, the acquisition premium and integration costs have temporarily compressed Torrent&#8217;s margins and return ratios.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_2_Germany_Business_%E2%80%94_Pricing_and_Competition\"><\/span><strong>Reason 2: Germany Business \u2014 Pricing and Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent has a significant Germany business (branded generics, approximately 15% of revenue) which faces intense pricing pressure from German health insurance companies (Krankenkassen) that mandate price competition among generic suppliers. Germany&#8217;s annual tender system creates margin uncertainty.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_3_Brazil_Business_%E2%80%94_Currency_Risk\"><\/span><strong>Reason 3: Brazil Business \u2014 Currency Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent&#8217;s Brazil operations are exposed to Brazilian Real (BRL) depreciation risk. A weaker BRL directly impacts the INR value of Brazil revenue, creating translation losses even if the local business is performing well.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_4_High_Working_Capital_in_Branded_Generics\"><\/span><strong>Reason 4: High Working Capital in Branded Generics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>India&#8217;s branded generics model requires maintaining a large field force, sample inventory, and distribution network. Working capital requirements are higher than generic pharmaceutical peers, which compresses return on capital employed.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_5_Valuation_vs_Growth_Justification\"><\/span><strong>Reason 5: Valuation vs Growth Justification<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>At 38x P\/E, Torrent Pharma needs to deliver consistent 15-18% PAT growth to justify the multiple. The combination of Curatio integration costs, Germany pricing pressure, and Brazil currency headwinds has created a period where growth is below this threshold.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Financial_Snapshot\"><\/span><strong>Torrent Pharmaceuticals Financial Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP<\/td><td>Rs 2,850<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 3,900<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 2,600<\/td><\/tr><tr><td>Decline from Peak<\/td><td>-27%<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 96,000 Cr<\/td><\/tr><tr><td>P\/E Ratio<\/td><td>38x<\/td><\/tr><tr><td>P\/B Ratio<\/td><td>7.5x<\/td><\/tr><tr><td>Promoter Holding<\/td><td>71.3%<\/td><\/tr><tr><td>FII Holding<\/td><td>12.6%<\/td><\/tr><tr><td>DII Holding<\/td><td>14.4%<\/td><\/tr><tr><td>Sector<\/td><td>Pharmaceuticals \/ Branded Generics<\/td><\/tr><\/tbody><\/table><\/figure><p>Track <strong>Torrent Pharmaceuticals<\/strong> live fundamentals and peer comparisons on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for daily research updates.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Can_Torrent_Pharmaceuticals_Recover_Future_Outlook\"><\/span><strong>Can Torrent Pharmaceuticals Recover? Future Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Torrent Pharmaceuticals is a high-quality branded generic company with strong domestic and international franchise. The current challenges are temporary \u2014 Curatio integration costs will normalise by FY27, and Germany\/Brazil will continue providing diversified international exposure. At Rs 2,850 and 38x P\/E, the stock offers reasonable value. Recovery to Rs 3,300-3,800 requires Curatio integration to show top-line synergies and India branded generics growth above 12%.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Share_Price_Target_2026\"><\/span><strong>Torrent Pharmaceuticals Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered analyst recommendations<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3-6_Months\"><\/span><strong>Short-Term Target (3-6 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Short-term Torrent Pharmaceuticals share price target is Rs 2,700-3,100, based on current technical setup and near-term fundamental catalyst timeline. The 52-week low of Rs 2,600 is the key support level \u2014 a sustained break below this would be a significant bearish signal.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Torrent Pharmaceuticals share price target is Rs 3,300-3,800, implying meaningful upside from the current Rs 2,850. This assumes the key headwinds identified in this article begin to resolve.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY28\"><\/span><strong>Long-Term Target (FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In a full recovery scenario, the Torrent Pharmaceuticals share price target for FY28 is Rs 4,500-5,200. This bull case requires the fundamental concerns in this article to show clear reversal over the next 4-6 quarters.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q1_Why_is_Torrent_Pharmaceuticals_share_price_falling_in_2026\"><\/span><strong>Q1. Why is Torrent Pharmaceuticals share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent Pharmaceuticals share price is falling primarily due to the reasons detailed in this article. The stock has declined -27% from its 52-week high of Rs 3,900 to the current Rs 2,850. Key factors include sector headwinds, earnings pressure, and broader market conditions. Review all factors before making any investment decision.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q2_What_is_Torrent_Pharmaceuticals_share_price_target_2026\"><\/span><strong>Q2. What is Torrent Pharmaceuticals share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Torrent Pharmaceuticals share price target is Rs 3,300-3,800. Short-term target is Rs 2,700-3,100 and long-term FY28 target in a recovery scenario is Rs 4,500-5,200. These are analyst estimates and not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q3_Should_I_buy_Torrent_Pharmaceuticals_at_current_levels\"><\/span><strong>Q3. Should I buy Torrent Pharmaceuticals at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not provide personalised investment advice. Torrent Pharmaceuticals is trading at Rs 2,850 with a 52-week range of Rs 2,600 to Rs 3,900. The risk-reward depends on your investment horizon and risk tolerance. Consult a SEBI-registered financial advisor before investing.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q4_What_is_Torrent_Pharmaceuticalss_market_cap_and_PE_ratio\"><\/span><strong>Q4. What is Torrent Pharmaceuticals&#8217;s market cap and P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent Pharmaceuticals&#8217;s market capitalisation is Rs 96,000 Cr with a trailing P\/E of 38x and price-to-book ratio of 7.5x. Promoter holding is 71.3%, FII 12.6%, DII 14.4%.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q5_What_can_trigger_recovery_in_Torrent_Pharmaceuticals_share_price\"><\/span><strong>Q5. What can trigger recovery in Torrent Pharmaceuticals share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Recovery triggers for Torrent Pharmaceuticals include: resolution of the specific headwinds identified in this article, positive quarterly results showing reversal of stressed metrics, and broad market recovery. Monitor quarterly results and management commentary closely.<\/p><p><strong>Disclaimer: <\/strong>For educational purposes only. Not investment advice. Consult a SEBI-registered financial advisor. Investments are subject to market risk.<\/p><p>For more analysis, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span>Recent Articles<span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-krbl-share-price-falling\"><strong>Why is KRBL Share Price Falling? Check Next Share Price Target\u00a0<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-reliance-infrastructures-share-price-falling\"><strong>Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-mahanagar-gas-share-price-falling\"><strong>Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-happiest-minds-share-price-falling\"><strong>Why is Happiest Minds Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Torrent Pharmaceuticals share price is down -27% from its 52-week high of Rs 3,900, trading at Rs 2,850 as of April 2026. At its 52-week low of Rs 2,600, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap? The<\/p>\n","protected":false},"author":27,"featured_media":70234,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3818],"class_list":["post-70232","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-falling"],"metadata":{"_edit_lock":["1776075310:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Why Is Torrent Pharmaceuticals Share Price Falling? Key Reasons &amp; Share Price Target 2026"],"rank_math_description":["Torrent Pharmaceuticals share price falling -27% from 52-week high. Find key reasons, analyst view and Torrent Pharmaceuticals share price target for 2026.\n"],"rank_math_focus_keyword":["Torrent Pharmaceuticals"],"_thumbnail_id":["70234"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7925"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/13154155\/torrent-pharmaceuticals-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=70232"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70232\/revisions"}],"predecessor-version":[{"id":70238,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70232\/revisions\/70238"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/70234"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=70232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=70232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=70232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}